{
    "data": [
        {
            "title": "UPS Restructuring Shifts From Amazon To Higher Margin Growth And Valuation",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>UPS (NYSE:UPS) is closing 22 union staffed sortation centers this year, as part of a plan that could shutter up to 200 facilities by 2030.</li> <li>The company is launching a voluntary buyout program for up to 105,000 drivers, targeting about 30,000 job reductions.</li> <li>The restructuring is tied to a pivot away from lower margin Amazon deliveries and toward areas such as healthcare logistics and automation.</li> </ul> <p>UPS, a global parcel delivery and logistics provider, is reshaping how its network is set up as e commerce and business shipping patterns evolve. The company is moving away from a heavy reliance on Amazon volumes and is putting more focus on higher margin categories like healthcare shipments and automated facilities. For investors, the changes highlight how management is rethinking where and how UPS earns its money.</p> <p>Looking ahead, the closures and driver buyout program could meaningfully alter UPS cost base and operational footprint by 2030. The key questions for shareholders will be how effectively UPS reallocates capacity to targeted growth areas and how the restructuring affects service quality, labor relations, and long term profitability.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">United Parcel Service</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/UPS\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on United Parcel Service.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UPS Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/9f1233af-7b08-4d3d-8a56-eac949949657/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UPS Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_risk_alert\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service\" rel=\"noopener noreferrer\" target=\"_blank\">We've flagged 3 risks for United Parcel Service. See which could impact your investment.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚öñÔ∏è Price vs Analyst Target</strong>: At US$116.63, UPS trades about 3% above the analyst target of US$113.18, within the 10% band that suggests no clear consensus skew.</li> <li><strong>‚úÖ Simply Wall St Valuation</strong>: Simply Wall St flags UPS as trading roughly 27.7% below its estimated fair value.</li> <li><strong>‚úÖ Recent Momentum</strong>: The 30 day return of about 8.8% shows positive short term price momentum.</li> </ul> <p>There is only one way to know the right time to buy, sell or hold United Parcel Service. Head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of United Parcel Service's Fair Value.</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The restructuring, facility closures and pivot away from Amazon volumes could reshape how UPS earns its US$88.7b in revenue over time.</li> <li>üìä Keep an eye on cost savings versus restructuring charges, P/E of 17.8 versus the logistics industry average of 19.1, and how healthcare and automation exposure develops.</li> <li>‚ö†Ô∏è With a 5.62% dividend not well covered by earnings or free cash flow, larger upfront restructuring costs or weaker cash generation would matter for income focused holders.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service\" rel=\"noopener noreferrer\" target=\"_blank\">complete United Parcel Service analysis</a>. Alternatively, you can check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/UPS\" rel=\"noopener noreferrer\" target=\"_blank\">community page for United Parcel Service</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:50:51",
            "link": "https://simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/news/ups-restructuring-shifts-from-amazon-to-higher-margin-growth",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Restaurant Brands Investor Day Clarifies Growth Targets And Simplification Plan",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Restaurant Brands International held its 2026 Investor Day, offering a midpoint update on its long-term plan.</li> <li>The company reaffirmed its multiyear growth targets and detailed progress on its existing initiatives.</li> <li>Management outlined a roadmap to simplify its structure, including plans to sunset the Restaurant Holdings segment by 2027.</li> <li>The event also highlighted priorities for capital allocation and operational focus over the medium term.</li> </ul> <p>Restaurant Brands International, traded as NYSE:QSR, entered this Investor Day with its shares at $69.89 and a return of 11.3% over the past year. Over a longer period, the stock has a 20.9% return over three years and 32.8% over five years, which gives investors some context for how the company has rewarded shareholders over different holding periods.</p> <p>For anyone following NYSE:QSR, the reaffirmed growth goals, structural simplification plans, and clarity on capital allocation provide additional inputs for thinking about the company over the next few years. This Investor Day also updates expectations around how management plans to run the business and where it intends to focus resources as it works toward its multiyear objectives.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Restaurant Brands International</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/QSR\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Restaurant Brands International.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:QSR Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/e4455ebd-1d99-43c2-b4cc-ee639087d66e/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:QSR Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_full_picture\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international\" rel=\"noopener noreferrer\" target=\"_blank\">üì∞ Beyond the headline: 3 risks and 2 things going right for Restaurant Brands International that every investor should see.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚öñÔ∏è Price vs Analyst Target</strong>: At $69.89 versus a consensus target of $77.76, the price sits about 10% below where analysts on average see it.</li> <li><strong>‚öñÔ∏è Simply Wall St Valuation</strong>: Shares are described as trading close to estimated fair value, so expectations from the Investor Day are largely reflected in the price.</li> <li><strong>‚úÖ Recent Momentum</strong>: A 30 day return of roughly 3.5% shows modest positive momentum into and around the event.</li> </ul> <p>To explore whether it may be the right time to buy, sell, or hold Restaurant Brands International, you can review Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of Restaurant Brands International's fair value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The Investor Day reaffirmation of multi year growth targets and the plan to sunset Restaurant Holdings by 2027 provide more clarity on how management intends to sharpen the core business.</li> <li>üìä Watch how margins, the P/E of 26.8 versus the 23.2 industry average, and progress on simplifying the structure track against this roadmap over the next few updates.</li> <li>‚ö†Ô∏è Key risks flagged include debt coverage by operating cash flow and a 3.72% dividend that is not well covered, so monitoring cash generation and payout sustainability as capital is redeployed may be important.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, you can review the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international\" rel=\"noopener noreferrer\" target=\"_blank\">complete Restaurant Brands International analysis</a>. You can also visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/QSR\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Restaurant Brands International</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:50:51",
            "link": "https://simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/news/restaurant-brands-investor-day-clarifies-growth-targets-and",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "California Water Service Group (CWT) Margin Compression Tests Bullish Earnings Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>California Water Service Group (CWT) has just wrapped up FY 2025 with fourth quarter revenue of US$220 million and basic EPS of US$0.19, alongside net income of US$11.5 million. The company has seen quarterly revenue move from US$222 million and EPS of US$0.33 in Q4 2024 to US$220 million and EPS of US$0.19 in Q4 2025. On a trailing 12 month basis, EPS was US$2.15 on revenue of about US$1.0 billion and net income of US$128.2 million, setting up a story where investors are weighing earnings growth forecasts against a thinner profit margin profile.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for California Water Service Group.</a> <p>With the headline numbers on the table, the next step is to see how this earnings print lines up with the widely followed narratives around CWT‚Äôs growth potential, risk profile, and long term profitability story.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/9t2mqp2i-capital-investment-in-water-infrastructure-will-expand-regulated-base-t1di\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about California Water Service Group</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CWT Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/64bc4bd4-6a65-4a95-8172-d50dd779dee2/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:CWT Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Margins Under Pressure At 12.8%</h2> <ul> <li>On a trailing 12 month basis, CWT earned US$128.2 million of net income on about US$1.0b of revenue. This works out to a 12.8% net margin compared with 18.4% the prior year.</li> <li>Analysts' consensus view is that long term earnings resilience will come from regulated rate relief and capital investment, and the current 12.8% margin puts extra focus on whether future rate decisions and PFAS cost recovery are enough to support that thesis.\n    <ul> <li>The consensus narrative points to expanding infrastructure and reuse projects as supporting future earnings stability. The drop from 18.4% to 12.8% shows how higher compliance and treatment costs can tighten margins in the meantime.</li> <li>With trailing 12 month net income at US$128.2 million versus US$190.8 million a year earlier, the story now hinges on whether future rate cases and cost recoveries can line up more closely with this higher investment and operating spend.</li> </ul> </li> </ul> <p>Bulls argue these margin pressures are temporary and tied to the timing of rate relief and PFAS recovery, not the earning power of the system over a full cycle. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ California Water Service Group Bull Case</strong></a></p> <h2>P/E Sits Between Industry Benchmarks</h2> <ul> <li>CWT currently trades on a 20.7x P/E, above the Global Water Utilities average of 16.8x but below the closer Water Utilities peer average of 24.8x.</li> <li>Bears focus on this mid range P/E together with weaker coverage ratios, arguing that paying more than the global sector average looks demanding while interest and dividends are not well covered.\n    <ul> <li>Consensus data indicates that interest payments are not well covered by earnings and that the 3.01% dividend yield is not well covered by free cash flow, which makes a 20.7x multiple look less comfortable for cautious investors.</li> <li>At the same time, five year earnings growth of 9.1% per year and forecast growth of about 9.6% per year show why some investors still accept a P/E above the global average, even with these balance sheet pressures.</li> </ul> </li> </ul> <p>Skeptics highlight that paying 20.7x earnings while interest and dividend coverage stay tight could leave less room for error if growth or regulation disappoint. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª California Water Service Group Bear Case</strong></a></p> <h2>DCF Fair Value Trails Share Price</h2> <ul> <li>The DCF fair value of US$39.61 sits below the current share price of US$44.59, while the consensus analyst target of US$52.00 is above where the stock trades today.</li> <li>What stands out in the consensus narrative is the gap between these valuation markers and the operational backdrop, where forecast earnings growth of about 9.6% per year and revenue growth of roughly 5.3% per year are being weighed against regulatory and PFAS related cost risks.\n    <ul> <li>The analyst target of US$52.00 assumes earnings rising from about US$135.8 million today to US$187.9 million by around 2028, so any delay in rate cases or higher than expected PFAS capex would matter a lot for whether that path is achieved.</li> <li>At the same time, forecasts for revenue to reach around US$1.1b by 2028 from roughly US$1.0b on a trailing 12 month basis illustrate how much of the valuation debate comes down to modest top line growth supporting higher margins and returns over time.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/9t2mqp2i-capital-investment-in-water-infrastructure-will-expand-regulated-base-t1di\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for California Water Service Group on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>Mixed signals so far, right? If you want to make up your own mind quickly, it is worth looking at the underlying numbers and weighing <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 3 important warning signs</a> for yourself.</p> <h2>See What Else Is Out There</h2> <p>CWT is working through thinner 12.8% margins, tighter interest and dividend coverage, and a P/E of 20.7x that some investors may find demanding.</p> <p>If those margin and coverage pressures make you uncomfortable, you might want to compare CWT with <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> that can handle earnings bumps with stronger cash coverage and less financial strain.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:50:51",
            "link": "https://simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group/news/california-water-service-group-cwt-margin-compression-tests",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Did Stronger 2025 Earnings and Unused Buybacks Just Shift Trisura Group's (TSX:TSU) Investment Narrative?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Trisura Group Ltd. recently reported its full-year 2025 results, with net income of CA$142.25 million versus CA$118.92 million a year earlier, and basic earnings per share from continuing operations rising to CA$2.98 from CA$2.49.</li> <li>Despite having active buyback programs announced in December 2024 and December 2025, Trisura did not repurchase any shares in the reported periods, signaling that earnings growth rather than capital returns has been the primary driver of its recent story.</li> <li>We‚Äôll now examine how this stronger full-year earnings performance, alongside unused buyback authorizations, may influence Trisura‚Äôs existing investment narrative.</li> </ul><p>This technology could replace computers: discover <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/282/quantum-computing-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 stocks that are working to make quantum computing a reality</a>.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Trisura Group Investment Narrative Recap</h2><p>To own Trisura, you need to believe in its specialty insurance model, disciplined underwriting, and the potential of its expanding U.S. platforms to compound earnings over time. The stronger 2025 net income and EPS support that core thesis, while the lack of buybacks so far does not materially change the near term focus on execution in U.S. specialty lines or the key risk that rapid expansion could test Trisura‚Äôs risk controls.</p> <p>The full year 2025 earnings release is the clearest link to this story, with net income rising to CA$142.25 million and basic EPS from continuing operations up to CA$2.98. For investors watching catalysts like U.S. growth and margin progression, this result anchors the narrative in actual performance rather than in the unused buyback programs, which so far sit more as optional tools than active drivers of shareholder returns.</p> <p>Yet behind the headline earnings progress, investors should be aware of the risk that scaling U.S. Surety and Specialty faster than risk controls can keep up...</p> <p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/ca/insurance/tsx-tsu/trisura-group-shares/gl6wdhyp-us-surety-and-specialty-expansion-will-open-new-opportunities-2wuy\" rel=\"noopener noreferrer\" target=\"_blank\">Read the full narrative on Trisura Group (it's free!)</a></p><p>Trisura Group's narrative projects CA$4.0 billion revenue and CA$208.8 million earnings by 2028. This requires 8.2% yearly revenue growth and about a CA$87 million earnings increase from CA$121.5 million today.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/ca/insurance/tsx-tsu/trisura-group-shares/gl6wdhyp-us-surety-and-specialty-expansion-will-open-new-opportunities-2wuy\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover how Trisura Group's forecasts yield a CA$56.75 fair value</a>, a 24% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSX:TSU 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/0ff90050-ee2d-4688-91ec-f300abf88494/chart/quote-price\" width=\"746\"/></a><figcaption>TSX:TSU 1-Year Stock Price Chart</figcaption></figure> <p>Two Simply Wall St Community valuations for Trisura span a wide CA$56.75 to CA$91.53 range, underscoring how differently private investors view its earnings power. Set this against the recent uplift in reported net income and EPS, and you can see why some market participants focus on execution risks in U.S. specialty lines while others concentrate on long term growth potential.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Explore 2 other fair value estimates on Trisura Group</a> - why the stock might be worth as much as 100% more than the current price!</p><h2>Reach Your Own Conclusion</h2><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p><ul><li>A great starting point for your Trisura Group research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Our free Trisura Group research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Trisura Group's overall financial health at a glance.</li></ul><h2>Searching For A Fresh Perspective?</h2><p>These stocks are moving-our analysis flagged them today. Act fast before the price catches up:</p><ul><li>AI is about to change healthcare. These <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/ca\" rel=\"noopener noreferrer\" target=\"_blank\">4 stocks are working on everything from early diagnostics to drug discovery</a>. The best part - they are all under $10b in market cap - there's still time to get in early.</li><li>The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434414/ai-penny-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 smaller AI-focused companies with strong growth potential</a> through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.</li><li>Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434418/rare-earth-metal-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">31 best rare earth metal stocks</a> of the very few that mine this essential strategic resource.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Trisura Group might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/ca/insurance/tsx-tsu/trisura-group-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:50:51",
            "link": "https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares/news/did-stronger-2025-earnings-and-unused-buybacks-just-shift-tr",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "NEXTDC H1 2026 Loss Of A$57.2 Million Tests Bullish Growth Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Data center operator NEXTDC (ASX:NXT) has posted its H1 2026 scorecard with trailing 12 month revenue of A$430.26 million and a loss per share of A$0.089, keeping the company in loss-making territory. The company has seen revenue move from A$195.22 million in H2 2024 to A$205.52 million in H1 2025 and A$221.69 million in H2 2025, while half year EPS tracked at losses of A$0.041, A$0.069 and A$0.028 over the same periods. This sets the scene for investors to weigh strong top line momentum against pressure on margins.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for NEXTDC.</a> <p>With the numbers on the table, the next step is to test them against the prevailing stories around NEXTDC, highlighting where the earnings release supports the narratives and where it pushes back.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ASX:NXT Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/b310dddd-b160-496d-aa26-e7835ce893fc/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>ASX:NXT Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Trailing Losses Still Meaningful At A$57.2 Million</h2> <ul> <li>On a trailing 12 month view to H1 2026, NEXTDC booked a net loss of A$57.2 million on A$430.3 million in revenue, with basic EPS at a loss of A$0.089 per share.</li> <li>Bears highlight that losses have grown at about 30.5% per year over the past five years, and this trailing 12 month loss sits in that context, while:\n    <ul> <li>Net income on a trailing basis was A$60.5 million in loss at H2 2025 and A$65.3 million in loss at H1 2025, so the current A$57.2 million loss still reflects a business that is not covering its costs.</li> <li>Half year figures also show losses each period, with A$17.9 million loss in H2 2025, A$42.7 million loss in H1 2025 and A$22.6 million loss in H2 2024, which supports the bearish focus on persistent negative earnings.</li> </ul> </li> </ul> <h2>High Revenue Growth Forecast Versus Ongoing Unprofitability</h2> <ul> <li>Revenue is forecast to grow at 26.93% per year, faster than the Australian market forecast of 6.1% per year, while forecasts also indicate NEXTDC is not expected to be profitable over the next three years.</li> <li>What stands out for a bullish view is that strong forecast revenue growth sits alongside continuing losses, which creates a clear tension, because:\n    <ul> <li>Recent half year revenue has moved from A$195.2 million in H2 2024 to A$205.5 million in H1 2025 and A$221.7 million in H2 2025, so the top line has been stepping up while net income for those halves remained in loss between A$17.9 million and A$42.7 million.</li> <li>On a trailing 12 month basis, revenue rose from A$400.7 million at H1 2025 to A$430.3 million at H1 2026, but basic EPS stayed in loss between A$0.089 and A$0.112 per share, which challenges any bullish assumption that revenue growth alone is quickly translating into profitability.</li> </ul> </li> </ul> Analysts and long term holders are watching whether this mix of 26.93% revenue growth and ongoing losses can eventually line up with a clearer path to profits, or whether expectations start to cool once the cash cost of that growth is front and centre. <a class=\"company-report-links\" data-vars-link-type=\"cta_consensus_narrative_link\" href=\"https://simplywall.st/stock/ASX/NXT\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üìä Read the what the Community is saying about NEXTDC.</strong></a> <h2>Rich P/S Multiple With Less Than One Year Cash Runway</h2> <ul> <li>The shares around A$14.34 trade on a P/S of 21.4x, compared with peers at 13x and a global IT industry average of 1.4x, while the company‚Äôs cash runway is flagged at less than one year.</li> <li>Critics argue this combination of a high sales multiple and short cash runway heightens financing risk, and the earnings profile backs up that concern, because:\n    <ul> <li>With trailing 12 month revenue of A$430.3 million and a net loss of A$57.2 million, NEXTDC is still consuming cash rather than generating it, which matters when runway is under a year.</li> <li>Forecasts that the company is not expected to be profitable over the next three years mean any additional capital, whether debt or equity, would likely be raised against that 21.4x P/S, which bears see as stretched versus both peers at 13x and the wider IT group at 1.4x.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on NEXTDC's <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\">growth</a> and its <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation</a> to see if today's price is a bargain. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> now so you don't miss the next big move.</p> <p>All this leaves a mixed picture. If you are unsure where you land, move quickly to check the full balance of risks and rewards in our <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>NEXTDC is still loss making with a A$57.2 million trailing loss, a rich 21.4x P/S multiple and a cash runway flagged at under one year.</p> <p>If that mix of high valuation and tight funding window feels uncomfortable, it is worth checking our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/au\" rel=\"noopener noreferrer\" target=\"_blank\">7 resilient stocks with low risk scores</a> to quickly focus on companies with more resilient profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if NEXTDC might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/au/software/asx-nxt/nextdc-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:45:55",
            "link": "https://simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/news/nextdc-h1-2026-loss-of-a572-million-tests-bullish-growth-nar",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At Kyndryl Holdings (KD) Valuation After Control Weaknesses And Executive Departures",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Kyndryl Holdings (KD) has been under pressure after disclosing material weaknesses in internal controls, delaying a quarterly filing, and announcing the abrupt exit of its CFO and General Counsel, developments now tied to multiple securities class actions.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Kyndryl Holdings.</a></p> <p>The accounting review and executive departures have clearly weighed on sentiment, with a 30 day share price return of 48.34% decline and a year to date share price return of 51.71% decline. The 1 year total shareholder return of 67.37% decline signals fading momentum despite recent AI and cybersecurity announcements.</p> <p>If you are reassessing your tech exposure after Kyndryl's recent volatility, it could be a good time to look at <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_ai_infrastructure\" href=\"https://simplywall.st/discover/investing-ideas/473744/ai-infrastructure-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">33 AI infrastructure stocks</a> as potential AI infrastructure opportunities beyond a single stock.</p> <p>With KD now trading at $12.31 and data implying a sizeable intrinsic and target price discount, the key question is whether current legal and control risks are already reflected in the price or whether the market still expects weaker growth ahead.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 35.2% Undervalued</h2> <p>At $12.31, the most followed narrative implies Kyndryl Holdings could trade closer to a fair value of $19, using a detailed cash flow and earnings framework.</p> <blockquote> <p><em>The company's focus on expanding AI, data, and cybersecurity services, supported by investments in proprietary initiatives like Kyndryl Bridge and new alliances such as Databricks, is allowing Kyndryl to address rising complexity and security requirements, supporting both higher margins and new revenue streams.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/p9m3ecoh-digital-transformation-and-hybrid-cloud-will-create-a-resilient-future-0mb6\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious what kind of revenue mix and profit profile could back that $19 fair value tag? The narrative leans on compound earnings growth, firmer margins, and a valuation multiple that steps down from today yet still assumes confidence in long term cash generation. The real story is in how modest top line assumptions and stronger profitability combine to get there. Want to see exactly how those moving parts add up?</p> <p><strong>Result: Fair Value of $19 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/p9m3ecoh-digital-transformation-and-hybrid-cloud-will-create-a-resilient-future-0mb6\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, you also have to weigh ongoing revenue pressure from legacy contracts, as well as the new legal, control, and filing issues that could reshape how confident the market feels about KD.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Kyndryl Holdings narrative.</a></p> <h2>Next Steps</h2> <p>Given all this, do you feel the story leans more toward concern or opportunity? Act while sentiment is still split and weigh both sides for yourself by checking out the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 2 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If this Kyndryl story has you rethinking your tech exposure, do not stop here. Use the screener to spot other ideas before the crowd moves on.</p> <ul> <li>Target long term compounders by reviewing our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 24 high quality undiscovered gems</a> that combine quality fundamentals with relatively low market attention.</li> <li>Prioritise resilience by focusing on companies in the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> where financial strength supports flexibility through different business conditions.</li> <li>Lock in cash flow potential by scanning the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a> that highlight income opportunities with higher yields than many headline names.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Kyndryl Holdings might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/software/nyse-kd/kyndryl-holdings/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:45:55",
            "link": "https://simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings/news/a-look-at-kyndryl-holdings-kd-valuation-after-control-weakne",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "BTB REIT Q4 FFO Loss Challenges Income Focused Bullish Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>BTB Real Estate Investment Trust (TSX:BTB.UN) FY 2025 Results at a Glance</h2> <p>BTB Real Estate Investment Trust (TSX:BTB.UN) has reported its FY 2025 numbers with fourth quarter revenue of $32.3 million and a net loss of $0.9 million, alongside a quarterly Funds From Operations loss of $27.2 million. Over recent quarters, revenue has held in a narrow band between $30.5 million and $34.4 million, while quarterly net income has ranged from a profit of $18.8 million in FY 2024 Q4 to a loss of $0.9 million in FY 2025 Q4. With trailing net profit margin at 17.2% versus 29.8% the prior year and interest coverage highlighted as a weak spot, the focus now is on whether BTB can steady cash flows and margins enough to support its current profile.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for BTB Real Estate Investment Trust.</a> <p>With the headline figures set, the next step is to see how these results line up against the widely held narratives around BTB‚Äôs growth, risk profile and income potential, and where the latest numbers start to challenge those views.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSX:BTB.UN Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/33eb3fb0-f5a1-45eb-b668-7a37cec69372/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>TSX:BTB.UN Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <h2>FFO swings from $10.2 million to a $27.2 million loss</h2> <ul> <li>BTB moved from Funds From Operations of $10.2 million in FY 2025 Q3 to a $27.2 million FFO loss in Q4, even though revenue sat in a tight band between $30.5 million and $34.4 million across the year.</li> <li>What stands out for a cautious, more bearish view is that this FFO volatility comes on top of slower trailing revenue growth of 2.6% per year and a lower net margin of 17.2%. Together, these figures point to earnings that are more sensitive to costs and interest expense than the long term 6.5% annual earnings trend might suggest.\n    <ul> <li>Trailing 12 month net income of $22.4 million is well below the $42.2 million level reported a quarter earlier on a trailing basis, which lines up with the weaker margin picture.</li> <li>Bears highlighting interest coverage as a major risk get some support here because weaker cash generation makes it harder to comfortably meet those interest payments.</li> </ul> </li> </ul> üìâ Skeptics who focus on that $27.2 million FFO loss may want the full cautionary case before deciding what comes next: <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª BTB Real Estate Investment Trust Bear Case</strong></a> <h2>Margins fall from 29.8% to 17.2%</h2> <ul> <li>Over the last 12 months, BTB‚Äôs net profit margin sits at 17.2%, down from 29.8% the prior year, even though trailing revenue held around $130.1 million to $131.8 million.</li> <li>Supportive investors who take a more bullish angle might argue that the 6.5% per year earnings growth over five years shows the business has produced profits over time. However, the latest year of weaker margins and negative earnings relative to that trend pushes them to focus on whether this is a temporary squeeze or a more persistent shift.\n    <ul> <li>The trailing 12 month net income of $22.4 million compares with $38.7 million a year earlier on a trailing basis, which is a clear step down even though revenue is broadly similar.</li> <li>With interest payments flagged as not well covered by earnings, the margin compression directly feeds into that risk, since there is less profit left after operating costs to service debt.</li> </ul> </li> </ul> <h2>P/E of 16.3x with a DCF fair value of $5.68</h2> <ul> <li>The units trade at a P/E of 16.3x versus a peer average of 11.4x and a Global REITs average of about 16x, while the DCF fair value used here is $5.68 per unit compared to a current price of $4.12. This implies roughly a 27.5% discount to that DCF fair value estimate.</li> <li>What is interesting for a valuation focused bullish angle is that, despite softer margins and weaker interest coverage, the P/E sits above peers yet the unit still screens at a discount to DCF fair value. This sets up a clear tension between earnings based multiples and cash flow based valuation.\n    <ul> <li>The trailing 12 month revenue growth rate of 2.6% per year, below the 6.1% Canadian market benchmark, helps explain why some investors might hesitate to pay more even with that DCF gap.</li> <li>At the same time, a 17.2% net margin and positive trailing net income of $22.4 million give bulls some hard numbers to point to when they argue the current $4.12 price already reflects a good part of the recent pressure.</li> </ul> </li> </ul> If you want to see how other investors are weighing that 27.5% DCF gap against the earnings pressure, it is worth checking what the community is debating around BTB right now: <a class=\"company-report-links\" data-vars-link-type=\"cta_consensus_narrative_link\" href=\"https://simplywall.st/stock/TSX/BTB.UN\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üìä Read the what the Community is saying about BTB Real Estate Investment Trust.</strong></a> <h2>Next Steps</h2> <p>Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on BTB Real Estate Investment Trust's <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\">growth</a> and its <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation</a> to see if today's price is a bargain. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> now so you don't miss the next big move.</p> <p>If this mix of pressure on FFO and interest coverage has you on the fence, take a moment to check the underlying drivers for yourself. Then weigh up the balance of <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 3 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>BTB‚Äôs sharp move from a $10.2 million FFO profit to a $27.2 million loss, weaker 17.2% margins and pressure on interest coverage all highlight a balance sheet that looks stretched.</p> <p>If that mix of FFO swings and interest coverage risk feels uncomfortable, you can quickly compare it with companies that score better on debt and cash strength using our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/ca\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (10 results)</a>.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if BTB Real Estate Investment Trust might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:45:54",
            "link": "https://simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/news/btb-reit-q4-ffo-loss-challenges-income-focused-bullish-narra",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Geron (GERN) Q4 Loss Of US$31.1 Million Tests Bullish Profitability Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Geron (GERN) has just posted its FY 2025 results, with Q4 total revenue of US$48.0 million and a basic EPS loss of US$0.05, alongside trailing twelve month revenue of US$183.9 million and a TTM basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move between US$39.6 million and US$49.0 million, while basic EPS losses have ranged from US$0.02 to US$0.05 per quarter. This sets the backdrop for how investors assess the current TTM net loss of US$85.8 million and the pressure this puts on margins.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Geron.</a> <p>With the headline numbers on the table, the next step is to line these results up against the main stories around Geron and see where the financials support those narratives and where they start to push back.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/iajwo4yv-aging-population-trends-will-expand-hematology-market-opportunity-sb98\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Geron</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:GERN Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/46c7021c-c6f2-4a96-8e04-ee2bca322ba5/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGS:GERN Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Losses stay wide at US$85.8 million TTM</h2> <ul> <li>Over the last twelve months, Geron booked a net loss of US$85.8 million on US$183.9 million of revenue, with quarterly net losses in FY 2025 ranging from US$16.4 million in Q2 to US$31.1 million in Q4.</li> <li>Consensus narrative points to a path toward higher margins, but the current loss base is still sizeable:\n    <ul> <li>Analysts see revenue growing about 56.2% per year with margins moving from a loss of 53.5% today to a 27.9% margin in around three years, while the latest TTM figures still show meaningful losses on US$183.9 million of revenue.</li> <li>This creates a gap between the balanced view that Geron can support positive earnings in future and the current picture, where every one of the last six reported quarters, including Q4 FY 2025, shows a net loss of at least US$16.4 million.</li> </ul> </li> </ul> <h2>P/S of 5.8x vs industry 12.5x</h2> <ul> <li>Geron is currently trading on a P/S of 5.8x, compared with 12.5x for the wider US biotech group and 6.9x for its peer set, while the shares trade at US$1.67 versus a DCF fair value input of about US$19.01.</li> <li>Bulls highlight this valuation gap as a key part of their case, but the earnings profile gives important context:\n    <ul> <li>Bullish expectations look for revenue growth of 65.9% per year and earnings of US$379.0 million by around 2028, yet the latest TTM net loss is US$85.8 million, so the step change from today‚Äôs loss-making base is large.</li> <li>At the same time, the current 5.8x P/S and the difference between the US$1.67 share price and the US$19.01 DCF fair value input heavily support the bullish argument that the market is pricing Geron well below those optimistic growth and margin assumptions.</li> </ul> </li> </ul> If you want to see how optimistic investors are connecting these numbers to a long term story, check out the detailed bull case for Geron: <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/0xbj3pwr-precision-medicine-and-telomerase-inhibition-will-expand-therapeutic-markets\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Geron Bull Case</strong></a> <h2>Five year loss trend vs 62.6% earnings growth forecast</h2> <ul> <li>Over the past five years, losses have widened at about 6.3% per year, and on the latest data Geron remains unprofitable, while forward-looking models point to earnings growth of about 62.6% per year and an expectation of profitability within roughly three years.</li> <li>Bears focus on this track record as a counter to the growth story:\n    <ul> <li>Skeptical views stress that recent history still shows a sequence of quarterly net losses, including US$31.1 million in Q4 FY 2025 and US$85.8 million over the latest twelve months, which they see as evidence that scaling revenue has not yet translated into positive earnings.</li> <li>Against that, the forecast path to profitability within three years and the projected 62.6% annual earnings growth directly challenge the bearish concern that losses will simply continue on the same 6.3% five year trend without improving.</li> </ul> </li> </ul> Skeptical about that improvement story? You can walk through the numbers behind the cautious view in more detail here: <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/cvtzbdzk-drug-pricing-controls-and-approval-delays-will-curb-viability\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Geron Bear Case</strong></a> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/iajwo4yv-aging-population-trends-will-expand-hematology-market-opportunity-sb98\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Geron on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If the mix of optimism and caution in Geron‚Äôs story leaves you unsure, take a closer look now and weigh the evidence for yourself. You can also review the company‚Äôs <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a> to see what other investors are focusing on.</p> <h2>See What Else Is Out There</h2> <p>Geron is still posting sizeable losses, with US$85.8 million TTM in the red and several years of unprofitable quarters, which may concern risk conscious investors.</p> <p>If that level of ongoing loss makes you want sturdier foundations, check out our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> to quickly spot companies with more resilient profiles today.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:45:54",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron/news/geron-gern-q4-loss-of-us311-million-tests-bullish-profitabil",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Universal Health Services Q4 EPS Strength Reinforces Bullish Margin Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Universal Health Services (UHS) has wrapped up FY 2025 with fourth quarter revenue of US$4.5b and basic EPS of US$7.19, backed by net income of US$445.9m. The company has seen quarterly revenue move from US$4.1b in Q4 2024 to US$4.5b in Q4 2025, while basic EPS stepped up from US$5.07 to US$7.19 over the same period. On a trailing twelve month view, net profit margin sits at 8.6% versus 7.2% a year earlier, giving investors a clearer view of how earnings are converting into profit.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Universal Health Services.</a> <p>With the latest numbers on the table, the next step is to see how this earnings profile lines up with the key narratives around UHS, highlighting where the story is confirmed and where expectations might need to be revisited.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/rdizidzn-lower-medicaid-payments-and-rising-costs-will-erode-margins\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Universal Health Services</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UHS Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/dc1969cb-1517-4f94-bfaa-fe82aca6adfc/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UHS Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>TTM earnings up 30.4% with profit margin at 8.6%</h2> <ul> <li>Over the trailing twelve months, UHS generated US$23.42 in basic EPS and US$1.5b in net income on US$17.4b of revenue, with net profit margin at 8.6% compared with 7.2% a year earlier.</li> <li>What stands out for the bullish view is that this 30.4% trailing earnings growth and higher margin line up with arguments about expanding behavioral health and outpatient capacity. At the same time, the consensus narrative also flags future Medicaid payment reductions, so current profitability and the longer term policy overhang are pulling in different directions.</li> </ul> <h2>Low 8.6x P/E against healthcare peers</h2> <ul> <li>UHS trades on a trailing P/E of 8.6x compared with 23.6x for the wider US healthcare industry and 27x for peers, even though trailing earnings have grown 30.4% year over year and have risen about 7.3% per year over the last five years according to the supplied data.</li> <li>Bulls point to this apparent valuation gap and recent earnings strength as support for their case that the company could justify higher pricing. Yet the current share price of US$204.33 still sits well below the cited DCF fair value of about US$588.00 and below the allowed analyst target of US$253.00, which means the bullish argument about underappreciated growth is being made against forecasts that show earnings and revenue growth of 3.1% and 4.2% per year respectively, both slower than the US market in the inputs.\n    <ul> <li>That tension between a low P/E and slower forecast growth is central to the bullish narrative that outpatient and behavioral expansion, plus technology efficiencies, could support higher margins than the consensus currently embeds.</li> <li>At the same time, the supplied data notes the stock trading materially below the DCF fair value and below US$253.00, which bullish investors treat as evidence that the market is not fully crediting the 30.4% trailing earnings growth and 8.6% margin achieved so far.</li> </ul> </li> </ul> <p>Bulls argue that the market is underestimating how sustained earnings growth and margin resilience could shift sentiment if current trends hold, especially with the stock on an 8.6x P/E and trading below both DCF fair value and the US$253.00 analyst target. <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/6pqkl3yw-new-outpatient-facilities-and-telehealth-will-unlock-secular-market-demand\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Universal Health Services Bull Case</strong></a></p> <h2>High debt and policy risks against slower 3.1% EPS growth</h2> <ul> <li>The inputs highlight a high level of debt on the balance sheet alongside forecast earnings growth of about 3.1% per year and revenue growth of 4.2% per year, both cited as slower than the broader US market even though trailing net income over the last year is US$1.5b.</li> <li>Bears focus on that leverage and on regulatory items such as expected US$360m to US$400m annual cuts to Medicaid supplemental payments by 2032, arguing that slower forecast growth plus higher interest and capital needs make it harder to sustain the 8.6% margin, even though recent results show improved profitability and 30.4% trailing earnings growth that so far have run ahead of those cautious assumptions.\n    <ul> <li>Critics highlight that if net benefit from Medicaid programs falls while revenue growth tracks closer to the 4.2% forecast, the combination of debt servicing and lower reimbursement could pressure earnings even if current EPS of US$23.42 on a trailing basis remains solid today.</li> <li>What challenges the bearish stance somewhat is that, despite these risks being flagged, analysts in the supplied data still reference earnings that have grown 7.3% per year over five years and a current margin above last year, which suggests the operational picture has been resilient so far even as future policy changes are being debated.</li> </ul> </li> </ul> <p>Skeptics warn that high leverage and policy changes could matter more than recent EPS strength, especially if future growth sits near 3.1% while debt stays elevated. <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/rdizidzn-lower-medicaid-payments-and-rising-costs-will-erode-margins\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Universal Health Services Bear Case</strong></a></p> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/rdizidzn-lower-medicaid-payments-and-rising-costs-will-erode-margins\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Universal Health Services on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With the bullish and bearish angles laid out, how do they stack up for you right now, and what feels most important for your own portfolio decisions? Our analysis flags both risks and rewards that investors are watching closely, so it is worth checking the full breakdown before you settle on a view, starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 1 important warning sign</a>.</p> <h2>Explore Alternatives</h2> <p>UHS carries high debt and faces potential Medicaid payment cuts, while forecast earnings and revenue growth in the supplied data sit at modest single digit rates.</p> <p>If that mix of leverage and policy risk feels heavy for your portfolio, take a look at our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> to find companies with steadier profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:36:35",
            "link": "https://simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services/news/universal-health-services-q4-eps-strength-reinforces-bullish",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Assessing BrightView Holdings (BV) Valuation After Expanded Golf Management Role At The Villages",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>BrightView Holdings (BV) shares are in focus after its BrightView Landscapes unit expanded its golf management role at The Villages in Florida, where it now oversees more than half of the community‚Äôs 400 golf holes.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for BrightView Holdings.</a></p> <p>The latest contract win comes as BrightView‚Äôs 30 day share price return of 5.39% and 90 day share price return of 10.06% point to building momentum. At the same time, the 3 year total shareholder return of about 12x contrasts with a 5 year total shareholder return decline of 12.86%.</p> <p>If this golf expansion has you thinking about longer term themes in infrastructure and services, it could be worth scanning our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_power_grid\" href=\"https://simplywall.st/discover/investing-ideas/473750/power-grid-technology-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">23 power grid technology and infrastructure stocks</a> as another way to look for potential opportunities.</p> <p>With BrightView shares up over the past 3 months and trading at a reported discount to some analyst and intrinsic value estimates, the key question is whether there is still an opportunity here or if the market is already pricing in future growth.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 15% Undervalued</h2> <p>BrightView Holdings' most followed narrative sets a fair value of about $16.34 per share, compared with the last close at $13.89. This frames the current debate around upside versus execution risk.</p> <blockquote> <p><em>The \"One BrightView\" strategy is driving substantial cost savings and operating leverage through procurement centralization, technology investments, and large-scale fleet upgrades, which is directly impacting operating margins and net earnings, with further margin expansion expected as these initiatives scale.</em></p> </blockquote> <p><em>Read the complete narrative.</em> <a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/oxqxa3ns-expansion-into-10-branches-will-secure-urban-green-demand-d4qd\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></p> <p>Curious what kind of revenue growth, margin lift, and future earnings multiple need to come together to support that fair value? The projections behind this story lean heavily on improving profitability, rising recurring revenue and a lower valuation multiple than many investors might assume. The full narrative lays out how those moving parts fit together and what would need to go right for the numbers to line up.</p> <p><strong>Result: Fair Value of $16.34 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/oxqxa3ns-expansion-into-10-branches-will-secure-urban-green-demand-d4qd\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, this story could look very different if macro headwinds keep delaying client projects, or if cost savings and project to maintenance conversions fall short of expectations.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this BrightView Holdings narrative.</a></p> <h2>Next Steps</h2> <p>If this mix of potential upside and clear risks leaves you on the fence, take time while the data is fresh to shape your own view with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 4 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If BrightView has you thinking more broadly about where to put your money to work next, do not stop here; widen your search before the market moves on.</p> <ul> <li>Target quality first by checking companies that combine strong fundamentals with sturdy finances through our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a>.</li> <li>Hunt for potential value by scanning our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a> that filters for companies with solid business profiles trading below their assessed worth.</li> <li>Prioritise resilience by reviewing our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> that highlights businesses with lower risk scores for steadier portfolio anchors.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if BrightView Holdings might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/commercial-services/nyse-bv/brightview-holdings/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:36:35",
            "link": "https://simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings/news/assessing-brightview-holdings-bv-valuation-after-expanded-go",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Reassessing Novo Nordisk (CPSE:NOVO B) After Sharp Share Price Declines",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are looking at Novo Nordisk and wondering whether the current share price still lines up with the company‚Äôs long term story, you are not alone.</li> <li>The stock last closed at DKK 238.6, with returns of 22.4% decline over 7 days, 39.4% decline over 30 days, 27.8% decline year to date, 61.8% decline over 1 year and 50.0% decline over 3 years, while the 5 year return stands at 19.6%.</li> <li>These swings have arrived alongside ongoing attention on Novo Nordisk‚Äôs role in diabetes and weight management treatments, as well as regulatory and competitive headlines that keep the company in the spotlight. Together, these factors help explain why the share price has been so reactive, as investors reassess expectations and risk.</li> <li>Against that backdrop, Novo Nordisk currently scores 5 out of 6 on our valuation checks, as shown by our <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score</a>. Next, we will look at how different valuation methods line up on the stock and finish with an approach that can give you an even clearer view of what the market is pricing in.</li> </ul> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_industry_underperformer\" href=\"https://www.simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/future\" rel=\"noopener noreferrer\" target=\"_blank\">Find out why Novo Nordisk's -61.8% return over the last year is lagging behind its peers.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Novo Nordisk Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and discounting them back to the present.</p> <p>For Novo Nordisk, the model uses a 2 stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is DKK 52,097.16m. Analyst and extrapolated projections suggest free cash flow reaching DKK 145,840.33m in 2030, with a path that includes DKK 41,926.80m in 2026 and DKK 207,436.58m in 2035. Simply Wall St uses analyst estimates where available, then extends them using its own growth assumptions for the later years.</p> <p>Discounting these projected cash flows back to today gives an estimated intrinsic value of DKK 1,072.30 per share. Compared with the recent share price of DKK 238.60, the DCF output suggests the market price is at a 77.7% discount to this estimate, which indicates that the stock appears materially undervalued on this model alone.</p> <p><strong>Result: UNDERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests Novo Nordisk is undervalued by 77.7%. Track this in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>, or discover <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">231 more high quality undervalued stocks</a>.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NOVO B Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/71be77aa-1311-4447-b4b8-bcb7f8815b88/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>NOVO B Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Novo Nordisk.</a></p> <h3>Approach 2: Novo Nordisk Price vs Earnings</h3> <p>For a profitable company like Novo Nordisk, the P/E ratio is a useful snapshot of how much investors are paying for each unit of earnings. It reflects what the market is willing to pay today for the company‚Äôs current profit stream.</p> <p>In simple terms, higher growth expectations and lower perceived risk tend to support a higher P/E, while slower expected growth or higher risk usually line up with a lower, more conservative P/E. Novo Nordisk currently trades on a P/E of 10.35x, compared with the Pharmaceuticals industry average of 22.54x and a peer average of 26.08x. That raw comparison alone might suggest the stock is priced more cautiously than many of its peers.</p> <p>Simply Wall St‚Äôs Fair Ratio for Novo Nordisk is 25.04x. This is a proprietary P/E level that reflects factors such as the company‚Äôs earnings growth profile, profit margins, risk characteristics, industry, and market cap. Because it builds in these company specific drivers, it can be more informative than a simple peer or industry comparison. With the current P/E of 10.35x sitting well below the Fair Ratio of 25.04x, the multiple based view points to the shares looking undervalued on earnings.</p> <p><strong>Result: UNDERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"CPSE:NOVO B P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/71be77aa-1311-4447-b4b8-bcb7f8815b88/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>CPSE:NOVO B P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/global\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 98 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Novo Nordisk Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way for you to attach a clear story about a company to the numbers you are seeing, including your view on fair value and your own assumptions for future revenue, earnings and margins.</p> <p>A Narrative connects three pieces you already think about: what you believe is happening in the business, how that might flow through to a financial forecast, and what that implies for a fair value you can compare with today‚Äôs share price.</p> <p>On Simply Wall St, Narratives are available on the Community page and are used by millions of investors, so you can quickly see different views on Novo Nordisk and how other investors translate their thesis into numbers without needing to build a full model yourself.</p> <p>Because each Narrative pairs a user‚Äôs fair value with the current market price, it gives you a practical way to decide whether the gap between value and price is wide enough for you to consider buying, waiting, or taking some money off the table, all within a consistent framework.</p> <p>Narratives stay current because they refresh when new information such as earnings releases, regulatory updates or major news is incorporated, so the story, forecast and fair value do not sit frozen in time.</p> <p>For Novo Nordisk right now, one investor Narrative on Simply Wall St estimates fair value at DKK 287.0 while another sits at DKK 1,036.18, which shows how two people looking at the same company can reach very different conclusions once they plug in their own expectations.</p> <p>Do you think there's more to the story for Novo Nordisk? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/CPSE/NOVO%20B\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"CPSE:NOVO B 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/71be77aa-1311-4447-b4b8-bcb7f8815b88/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>CPSE:NOVO B 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Novo Nordisk might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:36:34",
            "link": "https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/news/reassessing-novo-nordisk-cpsenovo-b-after-sharp-share-price",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Houlihan Lokey (HLI) Fairly Priced After Recent Share Price Softness And Strong Multi‚ÄëYear Gains",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Houlihan Lokey‚Äôs current share price reflects its true worth, you are not alone. This article is designed to help you size up what you are really paying for.</li> <li>The stock last closed at US$169.10, with returns of 1.8% over the past week, a 5.9% decline over the past month, a 4.1% decline year to date, a 0.5% gain over the past year, 86.6% over three years and 182.7% over five years, which may leave you questioning whether the recent path justifies today‚Äôs price tag.</li> <li>Recent company updates and sector news have kept Houlihan Lokey on investor watchlists, as corporate activity and advisory demand often steer sentiment around investment banks and financial advisors. These headlines give important context to the recent mix of short term softness and longer term strength in the share price.</li> <li>Right now Houlihan Lokey scores 2 out of 6 on our valuation checks, which you can see in detail in our <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score</a>. We will walk through the usual valuation approaches next and also point you to a more complete way of thinking about value at the end of the article.</li> </ul> <p>Houlihan Lokey scores just 2/6 on our valuation checks. See what other red flags we found in the <a class=\"company-report-links\" data-vars-link-type=\"cta_low_value_score\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">full valuation breakdown</a>.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Houlihan Lokey Excess Returns Analysis</h3> <p>The Excess Returns model looks at how much value a company creates above the return that shareholders are estimated to require. It starts from the equity on the balance sheet, then compares the company‚Äôs expected return on that equity to its estimated cost of equity.</p> <p>For Houlihan Lokey, the model uses a Book Value of US$32.92 per share and a Stable EPS of US$9.25 per share, based on weighted future Return on Equity estimates from 4 analysts. The Average Return on Equity used is 25.05%, while the Cost of Equity is US$2.91 per share, implying an Excess Return of US$6.34 per share. The model also factors in a Stable Book Value of US$36.95 per share, sourced from weighted future Book Value estimates from 4 analysts.</p> <p>Combining these inputs, the Excess Returns model arrives at an estimated intrinsic value of about US$178.83 per share. Compared with the recent share price of about US$169.10, this suggests the stock is around 5.4% undervalued. This sits within a reasonable margin of error rather than providing a clear bargain signal.</p> <p><strong>Result: ABOUT RIGHT</strong></p> <p>Houlihan Lokey is fairly valued according to our <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_fairly_valued\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Excess Returns</a>, but this can change at a moment's notice. Track the value in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_fairly_valued\" href=\"https://www.simplywall.st/watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_fairly_valued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted on when to act.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"HLI Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c70f2d67-69b8-455b-920e-4c3e95539baa/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>HLI Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Houlihan Lokey.</a></p> <h3>Approach 2: Houlihan Lokey Price vs Earnings</h3> <p>For profitable companies like Houlihan Lokey, the P/E ratio is a useful shorthand for how much you are paying for each dollar of earnings. It helps you compare what the market is currently willing to pay for the company‚Äôs earnings relative to other options.</p> <p>What counts as a reasonable P/E usually reflects two things: how quickly earnings are expected to grow, and how risky those earnings are perceived to be. Higher expected growth and lower perceived risk can justify a higher P/E, while slower growth or higher risk typically support a lower multiple.</p> <p>Houlihan Lokey currently trades on a P/E of 26.35x. That sits above both the Capital Markets industry average of 23.01x and the peer group average of 15.39x. Simply Wall St‚Äôs Fair Ratio for Houlihan Lokey is 16.22x, which is its proprietary view of what a balanced P/E could look like after factoring in earnings growth, industry, profit margins, market cap and company specific risks.</p> <p>This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for the company‚Äôs own characteristics rather than assuming one size fits all. With the current 26.35x P/E sitting above the 16.22x Fair Ratio, the shares look expensive on this metric.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:HLI P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c70f2d67-69b8-455b-920e-4c3e95539baa/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:HLI P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 20 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Houlihan Lokey Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your story about a company expressed through your own assumptions for fair value, future revenue, earnings and margins, linked to a forecast and then to a fair value that you can compare with today‚Äôs price. On Simply Wall St, within the Community page used by millions of investors, Narratives give you an easy way to set out that story in numbers, see how your view differs from others, and quickly spot when your Fair Value is above or below the current price. This can help you decide whether the stock fits your watchlist or portfolio. Narratives also refresh as new information such as news, earnings or updated analyst estimates are added, so your view does not stay frozen. For Houlihan Lokey, for example, one investor might align with the higher fair value view around US$242.55 per share while another might lean closer to the lower fair value of US$173 per share, and Narratives make those different perspectives clear and comparable in one place.</p> <p>Do you think there's more to the story for Houlihan Lokey? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/NYSE/HLI\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-hli/houlihan-lokey\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:HLI 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c70f2d67-69b8-455b-920e-4c3e95539baa/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:HLI 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Houlihan Lokey might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:36:34",
            "link": "https://simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/news/is-houlihan-lokey-hli-fairly-priced-after-recent-share-price",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "MiMedx Group (MDXG) Revenue Jump To US$118.1 Million Tests Slow Growth Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>MiMedx Group (MDXG) has wrapped up FY 2025 with fourth quarter revenue of about US$118.1 million and basic EPS of roughly US$0.10, while trailing twelve month figures sit at around US$418.6 million of revenue and US$0.33 of basic EPS. Over the past few quarters, the company has seen revenue move from US$84.1 million in Q3 2024 to US$92.9 million in Q4 2024 and then to US$118.1 million in Q4 2025, with quarterly basic EPS ranging from about US$0.05 to US$0.11 across that stretch. With a trailing net profit margin of 11.6%, the latest earnings print gives investors a clear view of a business that is currently generating consistent profits.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for MiMedx Group.</a> <p>With the headline numbers on the table, the next step is to see how this earnings story lines up against the widely followed narratives around MiMedx's growth, profitability, and longer term potential.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/r8eua6ul-aging-and-chronic-trends-will-redefine-surgical-and-wound-care-nrla\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about MiMedx Group</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqCM:MDXG Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/da86cace-6e02-47ab-b8cb-096c3db7abd9/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqCM:MDXG Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>TTM profit of US$48.6 million supports 11.6% margin story</h2> <ul> <li>Over the last twelve months to Q4 2025, MiMedx generated about US$418.6 million of revenue and US$48.6 million of net income, which lines up with the 11.6% net margin mentioned earlier and shows profit has stayed in the low double digits.</li> <li>Analysts' consensus view links this kind of profitability to long term earnings potential, yet the small move in net margin from about 12% to 11.6% shows that while the business is currently earning solid profits, it is not breaking away from margin pressure as clearly as the consensus narrative suggests.</li> </ul> <h2>Quarterly EPS range of US$0.05 to US$0.11 keeps growth grounded</h2> <ul> <li>Across the last six reported quarters, basic EPS has sat in a fairly tight band between roughly US$0.05 and US$0.11 per share, with Q4 2025 at about US$0.10 and trailing twelve month EPS at about US$0.33, which shows earnings are positive but not moving in a straight line.</li> <li>Supporters in the bullish camp point to strong clinical positioning and product expansion as drivers of long term earnings, yet the step up and down in quarterly EPS within this US$0.05 to US$0.11 range reminds you that even with those tailwinds, the earnings path has been bumpy rather than smooth so far.\n    <ul> <li>The bullish narrative highlights diversified product expansion and operational efficiencies as reasons to expect stronger earnings over time, while the actual EPS path from about US$0.05 in Q1 2025 to roughly US$0.11 in Q3 2025 and US$0.10 in Q4 2025 shows that cost and revenue timing still matter a lot quarter to quarter.</li> <li>Backers also argue that investments in clinical trials and new launches can support margin improvement, but with trailing twelve month net income of around US$48.6 million on US$418.6 million of revenue, the current earnings base is still modest compared with the growth ambitions in that bullish story.</li> </ul> </li> </ul> <p>Bulls argue there is more to this EPS trend than the last few quarters show, and if you want to see how they frame the upside case in detail you can check out <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ MiMedx Group Bull Case</strong></a></p> <h2>P/E of 15.1x vs slower 3.8% revenue forecast</h2> <ul> <li>MiMedx is reported on a trailing P/E of 15.1x compared with a DCF fair value of US$14.55 per share and a current share price of US$4.94, while revenue growth is projected at about 3.8% per year, which is slower than the 10.4% figure cited for the broader US market.</li> <li>Critics in the bearish narrative focus on reimbursement changes and a concentrated product set as reasons that growth could be pressured, and the combination of a 3.8% revenue growth forecast and a net margin close to 11.6% gives those worries some footing even though the current P/E is lower than the 23x industry average.\n    <ul> <li>The bearish view highlights potential Medicare reforms and possible market contraction as threats to both volumes and margins, and the already slower projected top line growth compared with the broader market shows why those policy shifts matter for future revenue lines.</li> <li>Concerns about reliance on a limited placental allograft portfolio also tie back to the 11.6% net margin, because if reimbursement or competing products affect that core segment, the current earnings level of roughly US$48.6 million on US$418.6 million of sales could be sensitive to any shock in that main business.</li> </ul> </li> </ul> <p>Skeptics watching that 15.1x P/E against slower projected growth may want to see how a more cautious case is laid out in full through <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª MiMedx Group Bear Case</strong></a></p> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/r8eua6ul-aging-and-chronic-trends-will-redefine-surgical-and-wound-care-nrla\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for MiMedx Group on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If the mix of bullish and cautious views here feels balanced, it is a good moment to look at the numbers yourself and move quickly to form your own stance, starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group\" rel=\"noopener noreferrer\" target=\"_blank\">5 key rewards</a>.</p> <h2>See What Else Is Out There</h2> <p>MiMedx's slower projected 3.8% revenue growth, modest EPS range, and sensitivity to reimbursement and product concentration leave plenty of questions about long term upside.</p> <p>If those growth and concentration pressures give you pause, it may be a good time to widen the lens and review <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>, where the focus is on finding companies whose current pricing already reflects more conservative expectations.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:30:52",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/news/mimedx-group-mdxg-revenue-jump-to-us1181-million-tests-slow",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "BlueNord (OB:BNOR) Q4 Profitability Surge Tests Bearish Earnings Decline Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>BlueNord (OB:BNOR) closed out FY 2025 with Q4 revenue of US$362 million and basic EPS of US$2.21, while trailing 12 month figures showed revenue of US$1.04 billion and EPS of US$3.74. Over the past few quarters, revenue has moved from US$192.9 million in Q4 2024 to US$171.1 million in Q1 2025, US$260.2 million in Q2, US$246 million in Q3, and then US$362 million in Q4, with quarterly EPS shifting from a loss of US$2.86 to profits between US$0.19 and US$2.21. With the company now profitable on a trailing basis, the latest numbers put the focus on how durable those margins look against softer forward forecasts and financing risks.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/no/energy/ob-bnor/bluenord-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for BlueNord.</a></p> <p>With the headline figures on the table, the next step is to see how this earnings profile lines up with the key narratives around BlueNord, and where the numbers start to challenge those stories.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/f5b80muw-tyra-redevelopment-and-north-sea-gas-will-secure-long-term-stability-1v14\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about BlueNord</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/no/energy/ob-bnor/bluenord-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"OB:BNOR Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/892e0a95-4069-4e21-93a5-9e6e7ed6d98c/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>OB:BNOR Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>TTM profit of US$97.5 million changes the story</h2> <ul> <li>On a trailing basis BlueNord earned US$97.5 million of net income and US$3.74 in EPS on US$1.04b of revenue, compared with a trailing loss of US$70.8 million a year earlier on US$702.3 million of revenue.</li> <li>Bulls highlight that this move into profitability, alongside reported 5 year earnings growth of 14.5% per year, fits their view that Tyra ramp up and lower lifting costs can support long duration cash generation, although forecasts of roughly 2.5% annual earnings declines over the next three years pull in the opposite direction.</li> </ul> <h2>Q4 margin jump vs weaker forward forecasts</h2> <ul> <li>In Q4 2025 BlueNord generated US$55.3 million of net income on US$362 million of revenue, after earlier 2025 quarters with net income between US$4.9 million and US$18.6 million on revenue between US$171.1 million and US$260.2 million, while forecasts point to about 2.5% annual earnings declines and 0.4% annual revenue declines over the next three years.</li> <li>Bears argue that expected revenue growth of 6.7% per year and margins rising to 8% in their narrative still sit against these softer aggregate forecasts and the company‚Äôs flagged issue that interest payments are not well covered by earnings, so they focus on the risk that periods like Q4 are hard to repeat consistently when production bottlenecks or higher operating costs show up.</li> </ul> <p>Bears warn that if you are relying on strong quarters like Q4 to continue while forecasts and interest coverage look tougher, it is worth reading the full cautious case in <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/7h75w8a9-update-for-bluenord\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª BlueNord Bear Case</strong></a></p> <h2>P/E of 13.3x and a huge DCF gap</h2> <ul> <li>With the shares at NOK502 and trailing EPS at US$3.74, the data shows a P/E of 13.3x versus a European Oil &amp; Gas average of 15.4x. A DCF fair value of NOK4,205.12 is very large compared with the current price and also sits well above the single analyst target level of NOK567.60 in the dataset.</li> <li>Supporters of the bullish view point to that gap to the DCF fair value and to the idea of revenue growing 13.3% per year with margins improving to 17.8%. The same dataset flags that earnings are forecast to decline about 2.5% per year instead, so the current 13.3x multiple and weaker interest coverage give you a useful check on how much of the optimistic scenario is already being tested by actual reported numbers.</li> </ul> <p>Bulls argue the current P/E and the wide gap to DCF fair value leave room if Tyra volumes and margins play out closer to their script, so if you want to see how they justify that stance, have a look at <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/bo2forfk-update-for-bluenord\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ BlueNord Bull Case</strong></a></p> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/f5b80muw-tyra-redevelopment-and-north-sea-gas-will-secure-long-term-stability-1v14\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for BlueNord on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If this mix of optimism and caution has you thinking, do not wait too long to weigh the trade off yourself and check the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/no/energy/ob-bnor/bluenord-shares\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>BlueNord‚Äôs story now includes weaker interest coverage, forecasts of small annual earnings and revenue declines, and questions over how repeatable strong quarters like Q4 really are.</p> <p>If you are uneasy about those pressure points and want companies where balance sheets play more defense, check our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/global\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (369 results)</a> before your next move.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if BlueNord might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/no/energy/ob-bnor/bluenord-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:30:52",
            "link": "https://simplywall.st/stocks/no/energy/ob-bnor/bluenord-shares/news/bluenord-obbnor-q4-profitability-surge-tests-bearish-earning",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "What Daiwa House Industry (TSE:1925)'s New U.S. Holding Structure and Higher Dividend Guidance Means For Shareholders",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Daiwa House Industry recently restructured its U.S. operations by creating CRC Holdings LLC in Delaware as a holding company for CastleRock Communities, while also issuing consolidated earnings guidance and increasing its expected year-end dividend for the fiscal year ending March 31, 2026.</li> <li>A distinctive aspect of this development is that CRC Holdings LLC now qualifies as a specified subsidiary, with capital stock of about US$528.61 million, indirectly 89.11% owned by Daiwa House through its U.S. holding company.</li> <li>Against this backdrop, we will examine how the new U.S. holding structure for CastleRock Communities shapes Daiwa House Industry‚Äôs broader investment narrative.</li> </ul><p>We've uncovered the <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/jp\" rel=\"noopener noreferrer\" target=\"_blank\">13 dividend fortresses</a> yielding 5%+ that don't just survive market storms, but thrive in them.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>What Is Daiwa House Industry's Investment Narrative?</h2><p>To own Daiwa House Industry, you need to be comfortable with a steady, mainly domestic real estate and construction business that is trying to deepen its U.S. footprint while keeping returns and dividends in focus. The CRC Holdings LLC restructuring looks more like plumbing than a major earnings swing in the near term; it is designed to make financing easier for CastleRock Communities rather than transform group profitability overnight. In the short run, the more visible catalysts are management‚Äôs guidance for FY 2026 and the step up in the year‚Äëend dividend, set against modest forecast growth and recent underperformance versus the broader Japanese market. The bigger risks still sit around leverage, cash flow coverage of dividends and the potential for overseas expansion to add complexity without offsetting returns.</p> However, there is one financing and balance sheet risk here that investors should not ignore.\nDaiwa House Industry's shares are on the way up, but they could be overextended by 15%. <a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/stocks/jp/real-estate-management-and-development/tse-1925/daiwa-house-industry-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover the fair value now</a>.<h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/jp/real-estate-management-and-development/tse-1925/daiwa-house-industry-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSE:1925 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/39d34d27-af63-4335-88cb-bd5046bbf6e7/chart/quote-price\" width=\"746\"/></a><figcaption>TSE:1925 1-Year Stock Price Chart</figcaption></figure> The Simply Wall St Community currently contributes 1 fair value view for Daiwa House Industry at ¬•4,869, showing how differently individual investors can assess the same business. Set this against the recent U.S. restructuring, which may influence financing flexibility and future returns in ways that are not yet fully reflected, and it becomes worth comparing several independent assessments before forming your own view.<p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/jp/real-estate-management-and-development/tse-1925/daiwa-house-industry-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Explore another fair value estimate on Daiwa House Industry</a> - why the stock might be worth as much as ¬•4869!</p><h2>Reach Your Own Conclusion</h2><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p><ul><li>A great starting point for your Daiwa House Industry research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/jp/real-estate-management-and-development/tse-1925/daiwa-house-industry-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 2 important warning signs</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/jp/real-estate-management-and-development/tse-1925/daiwa-house-industry-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Our free Daiwa House Industry research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Daiwa House Industry's overall financial health at a glance.</li></ul><h2>No Opportunity In Daiwa House Industry?</h2><p>The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:</p><ul><li>AI is about to change healthcare. These <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/jp\" rel=\"noopener noreferrer\" target=\"_blank\">6 stocks are working on everything from early diagnostics to drug discovery</a>. The best part - they are all under $10b in market cap - there's still time to get in early.</li><li>Outshine the giants: these <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434414/ai-penny-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 early-stage AI stocks could fund your retirement</a>.</li><li>This technology could replace computers: discover <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/282/quantum-computing-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 stocks that are working to make quantum computing a reality</a>.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:30:51",
            "link": "https://simplywall.st/stocks/jp/real-estate-management-and-development/tse-1925/daiwa-house-industry-shares/news/what-daiwa-house-industry-tse1925s-new-us-holding-structure",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Evaluating Pan American Silver‚Äôs Valuation After Record 2025 Results And A Higher Dividend",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Record 2025 results and higher dividend draw investor focus</h2> <p>Pan American Silver (TSX:PAAS) has come into focus after reporting record fourth quarter and full year 2025 results, alongside a higher dividend and a 2026 outlook calling for further silver production growth.</p> <p>For the fourth quarter, the company reported sales of US$1,179 million, compared with US$815 million a year earlier, and net income of US$452 million, compared with US$108 million. Basic and diluted earnings per share from continuing operations were US$1.07, compared with US$0.30 a year ago.</p> <p>Across 2025, sales were US$3.62b compared with US$2.82b a year earlier, while net income was US$978 million compared with US$112 million. Full year basic and diluted earnings per share from continuing operations were US$2.56, compared with US$0.31 in the prior year.</p> <p>Alongside the earnings release on February 18, 2026, Pan American Silver declared a cash dividend of US$0.18 per common share for the fourth quarter of 2025, payable on or about March 13, 2026, to shareholders of record as of March 2, 2026. The company described the dividend as an eligible dividend for Canadian income tax purposes and noted that any future dividends will remain at the discretion of its board.</p> <p>The company also updated the market on its share repurchase activity. From October 1, 2025 to December 31, 2025, Pan American Silver bought back 282,700 shares for US$15 million, representing 0.07% of its shares. This completed a program initiated on March 3, 2025, under which the company repurchased a total of 1,650,770 shares for US$46.1 million, representing 0.44% of its outstanding shares.</p> <p>Management has guided to a further 14% increase in silver production in 2026, supported by contributions from the Juanicipio mine and higher grades at Cerro Moro, and plans to release an updated technical report for the La Colorada Skarn project in the second quarter of 2026. These elements sit alongside record 2025 free cash flow and a series of recent dividend increases and form the backdrop for how investors may weigh Pan American Silver‚Äôs current valuation and risk profile.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Pan American Silver.</a></p> <p>Investors appear to be responding to the record 2025 results and higher dividend. The share price is at CA$92.37 with a 90 day share price return of 45.83%, while the 1 year total shareholder return of 171.88% and 3 year total shareholder return of roughly 4.7x point to strong longer term momentum.</p> <p>If this earnings driven move has you rethinking precious metals exposure, it could be worth scanning beyond a single name and checking out our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_silver\" href=\"https://simplywall.st/discover/investing-ideas/473743/top-silver-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">7 top silver producer stocks</a> as potential next ideas.</p> <p>With the shares up 46% in 90 days and trading slightly above the average analyst price target, yet still showing a large intrinsic value gap, is there still a buying opportunity here, or is the market already pricing in future growth?</p> <h2>Price-to-Earnings of 29.1x: Is it justified?</h2> <p>On earnings, the market is putting a 29.1x P/E on Pan American Silver at CA$92.37. This sits above both peers and the company‚Äôs own estimated fair ratio.</p> <p>The P/E multiple simply tells you how much investors are currently paying for each dollar of earnings. It is a common yardstick for metals and mining companies where profitability matters as much as production volumes.</p> <p>For Pan American Silver, that 29.1x P/E compares with a peer average of 26.4x and an estimated fair P/E of 26.4x. This indicates the market is applying a richer tag than both the sector and the level our fair ratio suggests the price could lean toward over time.</p> <p>Stacked against the broader Canadian Metals and Mining industry, where the average P/E is 22.5x, Pan American Silver‚Äôs 29.1x stands out as clearly higher. This signals that investors are currently pricing in stronger earnings prospects or a higher quality profile than the typical name in the group.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"fair_ratio_cta\" href=\"https://www.simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Explore the SWS fair ratio for Pan American Silver</a></p> <p><strong>Result: Price-to-Earnings of 29.1x (OVERVALUED)</strong></p> <p>However, you are paying that richer P/E in a sector exposed to metal price swings, as well as Pan American Silver‚Äôs multi country operating and regulatory risks.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Pan American Silver narrative.</a></p> <h2>Another view on value: SWS DCF points the other way</h2> <p>The P/E of 29.1x suggests Pan American Silver looks expensive, but our DCF model tells a different story. At CA$92.37, the shares trade about 57.6% below our estimate of fair value at CA$217.63. This frames the current price as a sizeable discount instead of a premium. So which signal do you trust more: earnings multiples or future cash flows?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_dcf_cta\" href=\"https://www.simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Look into how the SWS DCF model arrives at its fair value.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/ca/materials/tsx-paas/pan-american-silver-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"PAAS Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/32d0f89b-a81d-42bd-9deb-9557bcda8c33/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>PAAS Discounted Cash Flow as at Feb 2026</figcaption></figure><p> </p><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (<a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://www.simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares\" rel=\"noopener noreferrer\" target=\"_blank\">check out Pan American Silver for example</a>). We show the entire calculation in full. You can track the result in your <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted when this changes, or use our stock screener to discover <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/ca\" rel=\"noopener noreferrer\" target=\"_blank\">9 high quality undervalued stocks</a>. If you <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">save a screener</a> we even alert you when new companies match - so you never miss a potential opportunity.</p> <h2>Next Steps</h2> <p>Mixed signals or clear opportunity, either way it helps to move fast and pressure test the story for yourself by weighing up <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 2 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If this has sharpened your focus on opportunities, do not stop here. The right mix of stocks can matter more than any single position.</p> <ul> <li>Spot potential value plays early and check out our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/ca\" rel=\"noopener noreferrer\" target=\"_blank\">9 high quality undervalued stocks</a> that currently stand out on both quality and pricing.</li> <li>Strengthen your income stream by reviewing <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/ca\" rel=\"noopener noreferrer\" target=\"_blank\">5 dividend fortresses</a>, so you are not missing companies offering higher yields with robust payout records.</li> <li>Prioritize resilience and peace of mind by scanning <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/ca\" rel=\"noopener noreferrer\" target=\"_blank\">7 resilient stocks with low risk scores</a>, where the focus is on companies with lower risk scores and steadier profiles.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:30:51",
            "link": "https://simplywall.st/stocks/ca/materials/tsx-paas/pan-american-silver-shares/news/evaluating-pan-american-silvers-valuation-after-record-2025",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At FTI Consulting (FCN) Valuation After Strong Results And Upbeat 2026 Guidance",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Why FTI Consulting‚Äôs latest earnings matter for shareholders</h2> <p>FTI Consulting (FCN) just released fourth quarter and full year 2025 results alongside fresh 2026 guidance. This puts new numbers around how the business is performing today and what management expects next.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for FTI Consulting.</a></p> <p>The 5.1% 1 day share price return after the results, with the stock now at $168.11, comes after a mixed few months where a 30 day share price decline of 8.1% contrasts with a modestly positive 1 year total shareholder return of 2.0%. This suggests recent trading momentum has picked up as investors react to the earnings beat and 2026 guidance.</p> <p>If these earnings have you thinking about where professional services and technology intersect, it could be a good moment to check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_founder_led\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">20 top founder-led companies</a> as potential next ideas.</p> <p>With FTI Consulting posting higher quarterly sales and diluted EPS alongside 2026 guidance that points to more revenue and earnings, you now have to ask yourself whether there is still upside here or whether the market is already pricing in that growth.</p> <h2>Most Popular Narrative: 5.3% Undervalued</h2> <p>With FTI Consulting closing at $168.11 against a narrative fair value of $177.50, the current price sits below what this widely followed view considers reasonable, and that gap comes from some very specific assumptions about growth and profitability.</p> <blockquote> <p><em>The consulting industry's trend toward consolidation and the challenging macro climate are expected to drive \"shakeouts\" among weaker competitors, strengthening FTI's competitive position, client retention, and potential for market share gains, all of which could result in sustainable margin expansion and earnings growth.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/didodtsg-fcn-revenue-outlook-adjustments-and-cfo-transition-will-shape-next-chapter\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Want to see what sits behind that confidence in margins and earnings? The narrative leans on steady revenue progress, firmer profitability, and a future earnings multiple that is lower than many peers. The key point is how those moving parts line up over several years. If you want to understand the full playbook behind the $177.50 fair value, the complete narrative spells out every assumption.</p> <p>In this narrative, discounting future earnings back at just over 7% and pairing mid single digit revenue growth with higher profit margins creates a path that supports the current fair value estimate. Analysts also assume fewer shares on issue and a future P/E that is below where the broader professional services space sits today, which together help close the gap between today‚Äôs price and that $177.50 figure.</p> <p><strong>Result: Fair Value of $177.50 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/didodtsg-fcn-revenue-outlook-adjustments-and-cfo-transition-will-shape-next-chapter\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, there are clear watchpoints, including pressure on higher billing rates if competition intensifies and the risk that automation could chip away at some consulting demand.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this FTI Consulting narrative.</a></p> <h2>Another View: Cash Flows Tell A Different Story</h2> <p>While the narrative fair value of $177.50 suggests FTI Consulting is 5.3% undervalued, our DCF model points in the opposite direction, with the shares trading well above an estimated future cash flow value of $0.16. That is a very large gap. Which signal do you trust more: earnings power or cash flows?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_dcf_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Look into how the SWS DCF model arrives at its fair value.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/commercial-services/nyse-fcn/fti-consulting/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"FCN Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/40098b7d-2adb-4c5e-b295-ff1576b3672b/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>FCN Discounted Cash Flow as at Feb 2026</figcaption></figure><p> </p><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (<a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">check out FTI Consulting for example</a>). We show the entire calculation in full. You can track the result in your <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted when this changes, or use our stock screener to discover <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>. If you <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">save a screener</a> we even alert you when new companies match - so you never miss a potential opportunity.</p> <h2>Next Steps</h2> <p>With such mixed signals around value and earnings power, it makes sense to move quickly and examine the numbers yourself to decide what really matters. To see what the market is currently optimistic about, take a closer look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If this update has you rethinking where your next opportunity could come from, do not stop at one stock. Use the screener to quickly surface fresh ideas tailored to you.</p> <ul> <li>Target potential mispricings by scanning our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>, which combines quality fundamentals with prices that may not fully reflect them.</li> <li>Strengthen your income focus by reviewing <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a>, a set of companies offering yields that stand out for investors who care about regular cash returns.</li> <li>Prioritize resilience by checking the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a>, a group of businesses that score well on financial stability and measured risk factors.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting/news/a-look-at-fti-consulting-fcn-valuation-after-strong-results",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At New Oriental Education & Technology Group‚Äôs (EDU) Valuation After Recent Share Price Weakness",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Recent performance snapshot</h2> <p>New Oriental Education &amp; Technology Group (EDU) has recently drawn attention after a mixed run in its share price, with a 1 day return of 2.07% and a 7 day decline of 6.76%.</p> <p>Over the past month the stock is roughly flat, while the past 3 months show a total return of 8.99%. Over a 1 year period, the total return stands at 20.51%, set against a 3 year total return of 33.52% and a 5 year total return decline of 67.80%.</p> <p>The shares last closed at US$55.74, and the company currently carries a value score of 3 on the provided scale.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for New Oriental Education &amp; Technology Group.</a></p> <p>For New Oriental, the recent 7 day share price decline of 6.76% and a year to date share price decline of 3.61% sit alongside a 90 day share price return of 8.99% and a 1 year total shareholder return of 20.51%. This suggests momentum has cooled in the short term, while longer term holders have still seen gains.</p> <p>If this shift in sentiment has you thinking about where else capital could work hard, it might be a good moment to broaden your search and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_founder_led\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">20 top founder-led companies</a>.</p> <p>With New Oriental trading at US$55.74 and sitting at a discount to analyst targets and some intrinsic estimates, investors now face a key question: is this a genuine value opportunity, or is future growth already priced in?</p> <h2>Most Popular Narrative: 13.6% Undervalued</h2> <p>With New Oriental shares at US$55.74 against a narrative fair value of US$64.49, the current setup centers on whether its cash generation can justify that gap under a 7.74% discount rate.</p> <blockquote> <p><em>Continued investment and rollout of omnichannel online merge offline (OMO) and AI-driven systems are enabling operating leverage, cost reductions, and higher efficiency in delivery, which is already resulting in improved operating margins (410bps YoY in core business), supporting future earnings growth through both topline expansion and margin expansion.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/u6bu8xt3-analysts-raise-price-target-for-new-oriental-amid-resilient-margins-and-mixed-growth-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious what kind of revenue climb, margin shift, and future earnings multiple need to line up to support that valuation gap? The full narrative spells out the growth runway, profit profile, and re-rating assumptions that sit behind that US$64.49 figure.</p> <p><strong>Result: Fair Value of US$64.49 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/u6bu8xt3-analysts-raise-price-target-for-new-oriental-amid-resilient-margins-and-mixed-growth-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, that story could wobble if overseas study demand softens further, or if tougher competition in non academic segments squeezes margins more than expected.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this New Oriental Education &amp; Technology Group narrative.</a></p> <h2>Next Steps</h2> <p>If this mix of upside potential and risks leaves you on the fence, now is a good time to check the data yourself and pressure test the story. To see what more optimistic investors are focusing on, take a look at <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If New Oriental has sharpened your thinking, do not stop with one stock. Use the tools at your fingertips to compare different themes, risk levels, and income profiles before you commit fresh capital.</p> <ul> <li>Target potential value opportunities by checking companies that screen as attractively priced with solid fundamentals through <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>.</li> <li>Strengthen the defensive side of your portfolio by focusing on companies with cash rich, resilient balance sheets using the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a>.</li> <li>Set up a reliable income stream by reviewing companies highlighted as higher yielding payers in the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a>.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if New Oriental Education &amp;amp; Technology Group might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group/news/a-look-at-new-oriental-education-technology-groups-edu-valua",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Northland Power Q4 Profitability Contrasts With Trailing Losses And Tests Bullish Earnings Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Northland Power FY 2025 earnings snapshot</h2> <p>Northland Power (TSX:NPI) closed out FY 2025 with Q4 revenue of C$725.3 million and basic EPS of C$0.95, while its trailing 12 month profile still reflects a loss with EPS at C$0.62 and net income of C$163.2 million. The company has seen quarterly revenue move from C$582.3 million in Q4 2024 to C$725.3 million in Q4 2025, alongside EPS shifting from C$0.49 to C$0.95 over the same period. This sets up an earnings picture where recent quarterly profitability contrasts with a loss making trailing 12 month base. For investors, the mix of positive Q4 earnings on top of loss making full year figures keeps the spotlight firmly on how margins hold up from here.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Northland Power.</a> <p>With the headline numbers on the table, the next step is to see how this earnings profile lines up against the key narratives around Northland Power's profitability, growth potential, and risk profile that investors have been talking about.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/n65x0uiq-grid-storage-and-offshore-wind-will-deliver-a-brighter-future-uxos\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Northland Power</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSX:NPI Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/eb1e3ff3-ac2f-404c-899f-e4a48d235412/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>TSX:NPI Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <h2>Loss making over C$160 million on a 12 month view</h2> <ul> <li>On a trailing 12 month basis to Q4 2025, Northland Power recorded total revenue of about C$2.4b and a net loss of C$163.2 million, which contrasts with Q4 alone showing net income of C$249.5 million.</li> <li>What stands out for the bearish narrative is that this 12 month loss comes after multiple loss making quarters, including Q3 2025 net loss of C$414.0 million and Q2 2025 net loss of C$64.1 million. Critics argue this keeps cash flow and long term earnings visibility under pressure even as individual quarters like Q4 look strong.\n    <ul> <li>Bears also point to weak coverage of interest costs and dividends, with earnings currently not covering a 3.32% dividend yield or interest expense. This ties directly into concerns about elevated debt and C$9b already spent plus C$6b still expected on Baltic Power and Hai Long.</li> <li>At the same time, consensus commentary about step changes in EBITDA from new offshore wind and storage projects is hard to reconcile with the recent pattern of trailing losses, including a trailing loss of C$285.9 million just one quarter earlier in Q3 2025.</li> </ul> </li> </ul> Northland‚Äôs recent loss pattern and debt funded build out give cautious investors plenty to question in the more optimistic forecasts of future earnings power. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª Northland Power Bear Case</strong></a> <h2>Slow 1.7% revenue growth versus wider market</h2> <ul> <li>Over the past 12 months, revenue has grown by about 1.7% per year compared to a 6.1% per year forecast for the Canadian market, even though quarterly revenue moved from C$582.3 million in Q4 2024 to C$725.3 million in Q4 2025.</li> <li>Analysts' bullish case leans heavily on new projects like Hai Long and Baltic Power and on grid scale storage, arguing that these additions can lift margins from about 2.3% loss making levels today toward 16.5% over three years. However, the current modest 1.7% revenue growth rate and history of wind resource issues and curtailments in places like the German offshore assets show how sensitive actual revenue can be to weather and power price conditions.\n    <ul> <li>On the supportive side for bulls, Q4 2025 revenue of C$725.3 million and net income of C$249.5 million follow Q4 2024 revenue of C$582.3 million and net income of C$126.8 million, which aligns with the view that new assets and better contract mix can improve earnings in stronger periods.</li> <li>Against that, the same 12 month data set still shows the business unprofitable and dropping several onshore and battery projects in Ontario, Alberta, and New York. This pushes back on the idea that growth from here is straightforward or that all pipeline projects will translate into higher revenue.</li> </ul> </li> </ul> For investors weighing that slower 1.7% revenue growth against the big project pipeline, it helps to see how others frame the trade off between new capacity, weather risk, and contract quality. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ Northland Power Bull Case</strong></a> <h2>Valuation sits below both DCF fair value and peers</h2> <ul> <li>At a current share price of C$21.69, Northland Power trades below the DCF fair value of about C$23.78 and at a P/S of 2.3x, compared with 3.0x for the broader North American renewable energy industry and 3.5x for peers.</li> <li>Consensus narrative suggests that expansion into grid scale storage and offshore wind and the use of long term, inflation linked contracts could justify these lower multiples over time. Yet the combination of a trailing loss of C$163.2 million and interest expenses that are not well covered by earnings means the current discount can also be read as the market pricing in balance sheet risk and a reliance on analyst forecasts that expect earnings of C$454.1 million by around 2028.\n    <ul> <li>The spread between the share price of C$21.69 and DCF fair value of C$23.78, plus a forecast earnings growth rate of about 40% per year and an analyst target of C$22.42, are the main numbers backing the view that the shares are not expensive\n<h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/n65x0uiq-grid-storage-and-offshore-wind-will-deliver-a-brighter-future-uxos\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Northland Power on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With bulls and bears both making strong cases here, it is worth getting familiar with the full set of numbers and forming your own view quickly. To see how concerns stack up against potential upside, take a look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 2 important warning signs</a> and judge the balance for yourself.</p> <h2>Explore Alternatives</h2> <p>Northland Power is still working through a C$163.2 million loss on a 12 month view, modest 1.7% revenue growth, and debt related concerns.</p> <p>If that combination of recent losses and balance sheet pressure feels uncomfortable, you can quickly compare it with companies in our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/ca\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (10 results)</a> that prioritize financial resilience.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p></li></ul></li></ul><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Northland Power might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/ca/utilities/tsx-npi/northland-power-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares/news/northland-power-q4-profitability-contrasts-with-trailing-los",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Chime Financial (CHYM) Q2 Loss Of US$923m Fuels Bearish Profitability Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Chime Financial (CHYM) closed out FY 2025 with Q4 revenue of US$596.4 million and a basic EPS loss of US$0.12. Trailing 12 month figures show revenue of about US$2.2 billion and a basic EPS loss of US$4.27, keeping the story firmly in loss-making territory. Over recent periods the company has seen revenue move from US$475.2 million in Q4 2024 to US$596.4 million in Q4 2025. This has come alongside quarterly EPS that has swung between a profit of US$0.20 in Q1 2025 and a loss of US$7.29 in Q2 2025, so investors are watching how quickly that volatility settles into more stable margins.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Chime Financial.</a> <p>With the latest numbers on the table, the next step is to see how this mix of rapid revenue progress and uneven profitability lines up with the key narratives investors have been using to frame Chime Financial‚Äôs story.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/tgtbueur-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Chime Financial</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:CHYM Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/93e8c166-1574-412a-8955-93ccc8007b9e/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGS:CHYM Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Revenue Nears US$2.2b While Losses Remain Heavy</h2> <ul> <li>On a trailing 12 month basis, Chime generated about US$2.2b of revenue against a net loss of roughly US$1.0b, so this is a business with strong top line scale that is still firmly in loss making territory.</li> <li>What stands out for the bullish narrative is that analysts are pairing this 30.7% revenue growth over the last year with forecast earnings growth of about 116.54% per year,\n    <ul> <li>Revenue moving from US$1.7b to about US$2.2b over the last 12 months aligns with the bullish view that digital banking adoption and higher value products like MyPay and Chime Card can support future growth.</li> <li>At the same time, the current trailing 12 month loss of roughly US$1.0b is a reminder that the optimistic margin assumptions in the bullish case depend on a significant shift from today‚Äôs loss making base.</li> </ul> </li> </ul> <p>Some bulls argue this mix of US$2.2b in revenue and heavy current losses could be the setup for a sharp earnings swing if their margin expectations play out, but they are starting from a very loss heavy year.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/tgtbueur-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Chime Financial Bull Case</strong></a> <h2>Quarterly Profit Swings Highlight Execution Risk</h2> <ul> <li>Within FY 2025, net income ranged from a profit of US$12.9 million in Q1 to a loss of US$923.4 million in Q2, with Q3 and Q4 losses of US$54.7 million and US$44.8 million, so profitability has moved around a lot within a single year.</li> <li>Bears focus on this pattern when they question how smooth the road to profitability might be,\n    <ul> <li>The very large loss in Q2 2025, alongside much smaller losses in Q3 and Q4, supports the cautious narrative that scaling products like MyPay and instant loans could expose Chime to earnings volatility if credit costs or operating expenses spike again.</li> <li>Even with revenue between US$518.7 million and US$596.4 million across the 2025 quarters, the shift from a small profit in Q1 to sizable losses later in the year gives skeptics concrete data to reference when they argue that earnings quality is still unproven.</li> </ul> </li> </ul> <p>Skeptical investors often point to the jump from a US$12.9 million profit to a US$923.4 million loss within the same year as a key reason to treat any profitability timelines with caution.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/q2p2b8jf-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Chime Financial Bear Case</strong></a> <h2>Premium P/S Multiple Relies On Growth Story</h2> <ul> <li>Chime is trading on a P/S ratio of 4.2x compared with peers at 2.0x and the US Diversified Financial industry at 2.4x, so the market is currently valuing each dollar of Chime‚Äôs sales at a clear premium to its reference group.</li> <li>Consensus narrative ties that higher multiple to expectations for faster growth,\n    <ul> <li>Forecast revenue growth of 16.7% per year compared with 10.4% for the broader US market is one reason investors may be comfortable paying more than peers for each dollar of current revenue.</li> <li>At the same time, the company is still loss making on a trailing 12 month basis, so the premium P/S ratio is being supported by growth forecasts rather than current profitability, which leaves less room if those forecasts are revised lower.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/tgtbueur-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Chime Financial on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If the combination of strong revenue scale, heavy losses and competing narratives leaves you unsure, take a moment to review the numbers yourself. Move quickly to form your own stance, then check what our data driven view highlights with <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards</a>.</p> <h2>See What Else Is Out There</h2> <p>Chime Financial combines roughly US$2.2b of revenue with heavy losses and sharp quarterly profit swings, so earnings quality and consistency remain key pressure points.</p> <p>If that level of earnings volatility has you wanting something steadier, check out our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> built to highlight companies with more consistent performance profiles today.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial/news/chime-financial-chym-q2-loss-of-us923m-fuels-bearish-profita",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        }
    ]
}